Market Research Report
U.S. Spinal Implants & VCF Device Market Analysis-COVID19-2019-2025-MedSuite-Includes: Cervical Fixation, Thoracolumbar Fixation, Motion Preservation, Vertebral Compression Fracture, Spinal Surgery Instrumentation & Interbody Devices
|Published by||iData Research Inc.||Product code||1000909|
|Published||Content info||584 Pages
Delivery time: 1-2 business days
|U.S. Spinal Implants & VCF Device Market Analysis-COVID19-2019-2025-MedSuite-Includes: Cervical Fixation, Thoracolumbar Fixation, Motion Preservation, Vertebral Compression Fracture, Spinal Surgery Instrumentation & Interbody Devices|
|Published: March 19, 2021||Content info: 584 Pages||
Throughout this medical market research, the publisher analyzed 50+ Spinal Implant & Vertebral Compression Fracture (VCF) Device companies in the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this report suite report contains all of the U.S. Spinal Implant & VCF Device market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Overall, the U.S. spinal implant and VCF market was valued at $5.18 billion in 2020. This is expected to increase over the forecast period to exceed $6.3 billion in 2025.
The greatest limiting factor for the spinal fusion markets is the growth of competing technologies, including minimally invasive surgeries and motion preservation technology. Lumbar artificial discs (LADs) have not been as successful at cannibalizing thoracolumbar fixation devices as previously anticipated, due to a lack of reimbursement and unfavorable clinical results, however cervical artificial discs (CADs) have seen strong growth. Favorable reimbursement policies are expected for these devices as favorable clinical results involving newer devices emerge.
Medtronic leads the U.S. spinal implant and VCF market. The company leads the cervical fixation, thoracolumbar fixation and VCF segments of the market, and came in very close second to DePuy Synthes in the interbody segment. Medtronic's strong position in the VCF market can be attributed to Kyphon's former monopoly of the percutaneous vertebral augmentation market, with its kyphoplasty product. Medtronic also released its Prestige® CAD, one of only two CADs available on the U.S. market, in 2009.